Tag Archive for: pharmaceutical
MBTAAnalysis: A look inside the MBTA
0 Comments
/
The MBTA shuttles over a million passengers a day around Greater…
Ruining Research Rewards: Price Controls Come for University Patents and Products
Joe Selvaggi talks with Pioneer Institute Senior Fellow Dr. Bill Smith about the benefit of the Bayh-Dole Act’s protection of intellectual property rights for university research patents and the risk posed to the nation and the local economy from recent efforts to consider price controls on products developed from patented discoveries.
ICER Proves Its Lack of Business Acumen, Again
A recent Institute for Clinical and Economic Review (ICER) “Report on Unsupported Price Increases,” concluded that: “Among the top drugs with price increases in 2019…ICER determined that seven of 10 lacked adequate new evidence to demonstrate a substantial clinical benefit that was not yet previously known.” The impression left by the report is that drug companies arbitrarily raise prices without good reason. As with so many ICER products, the study is misleading and demonstrates a profound lack of business acumen.
Study: Are Drug Prices Driving Healthcare Cost Growth?
Study: Requiring Drug Companies to Disclose Price Methodologies,…